Ultrastructural Characteristics (or Evaluation) of Creutzfeldt-Jakob Disease and Other Human Transmissible Spongiform Encephalopathies or Prion Diseases

REFERENCES

• Liberski PP. Prion diseases: a riddle wrapped in a mistery inside enigma. Folia Neuropathol. 2008;46(2):93–116.
   PubMedGoogle Scholar
• Liberski PP, Brown DR, Sikorska B, Caughey B, Brown P. Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropathol. 2008;46:1–25.
   Google Scholar
• Brown P, Goldfarb LG, Gajdusek DC. The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist. Lancet. 1991;337:1019–1022.
   PubMedGoogle Scholar
• Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning in an era. Neurology. 2006;67:389–393.
   PubMed Web of Science ®Google Scholar
• Almer G, Hainfellner JA, Brucke T, et al. Fatal familial insomnia: a new Austrian family. Brain. 1999;122:5–16.
   PubMed Web of Science ®Google Scholar
• Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258:806–808.
   PubMed Web of Science ®Google Scholar
• Parchi P, Castellani R, Cortelli P, et al. Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol. 1995;38:21–29.
   PubMed Web of Science ®Google Scholar
• Gambetti P, Parchi P, Chen SG. Hereditary Creutzfeldt-Jakob disease and fatal familial insomnia. Clin Lab Med. 2003;23:43–64.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol. 2002;249:1567–1582.
   PubMed Web of Science ®Google Scholar
• Bruce ME, Will RG, Ironside JW, et al. Transmission of mice indicate that “new variant” CJD is caused by the BSE agent. Nature. 1997;389:498–501.
   PubMed Web of Science ®Google Scholar
• Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature. 1996;383:685–670.
   PubMed Web of Science ®Google Scholar
• Deslys JP, Lasmezas C, Streichenberger N, et al. New variant Creutzfeldt-Jakob disease in France. Lancet. 1997;349:30–31.
   PubMedGoogle Scholar
• Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature. 1997;389:448–450.
   PubMed Web of Science ®Google Scholar
• Scott MR, Will R, Ironside J, et al. Compelling transgenic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA. 1999;96:15137–15142.
   PubMed Web of Science ®Google Scholar
• Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347:921–925.
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Prion Biology and Diseases. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2004.
   Google Scholar
• Weissmann C. Birth of a prion: spontaneous generation revisited. Cell. 2005;122:165–168.
   PubMed Web of Science ®Google Scholar
• Budka H, Aguzzi A, Brown P, et al. Consensus report: neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;4:459–466.
   Google Scholar
• Merz PA, Somerville RA, Wisniewski HM, Iqbal J. Abnormal fibrils from scrapie-infected brain. Acta Neuropathol (Berl). 1981;60:63–74.
   Google Scholar
• Merz PA, Rohwer RG, Kascak R, et al. Infection specific particle from the unconventional slow virus diseases. Science. 1984;225:437–476.
   PubMed Web of Science ®Google Scholar
• McKinley MP, Bolton DC, Prusiner SB. A protease resistant protein is a structural component of the scrapie prion. Cell. 1983;35:57–62.
   PubMed Web of Science ®Google Scholar
• Dealler S, Rainov NG. Pentosan polysulfate as a prophylactic and therapeutic agent against prion disease. IDrugs. 2003;6:470–478. Erratum in IDrugs. 2004; 7:88.
   PubMedGoogle Scholar
• Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology. 1987;37:895–904.
   PubMed Web of Science ®Google Scholar
• Liberski PP, Streichenberger N, Giraud P, et al. Ultrastructural pathology of prion diseases revisited: brain biopsy studies. Neuropathol Appl Neurobiol. 2005;31:88–96.
   PubMed Web of Science ®Google Scholar
• Liberski PP, Sikorska B, Hauw JJ, et al. Tubulovesicular structures are a consistent (and unexplained) finding in the brains of humans with prion diseases. Virus Res. 2008;132:226–228.
   PubMedGoogle Scholar
• Liberski PP, Budka H, Sluga E, Barcikowska M, Kwiecinski H. Tubulovesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 1992;84:238–243.
   PubMedGoogle Scholar
• Streichenberger N, Jordan D, Verejan I, et al. The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol (Berl). 2000;99:704–708.
   PubMedGoogle Scholar
• Sikorska B, Liberski PP, Sobow T, Budka H, Ironside JW. Ultrastructural study of florid plaques in variant Creutzfeldt-Jakob disease: a comparison with amyloid plaques in kuru, sporadic Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker disease. Neuropathol Appl Neurobiol. 2009;35(1):46–59. [Epub ahead of print 2008 May 30]
   PubMed Web of Science ®Google Scholar
• Hainfellner J, Brantner-Inhaler S, Cervenakova L, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol. 1995;5:201–213.
   PubMedGoogle Scholar
• Liberski PP, Budka H. Ultrastructural pathology of Gerstmann-Sträussler-Scheinker disease. Ultrastruct. Pathol. 1995;19:23–36.
   PubMed Web of Science ®Google Scholar
• Boellaard JW, Schlote W. Subakute spongiforme Encephalopathie mit multiformer Plaquebildung: Eigenartige familiar-hereditare Kranknheit des Zentralnervensystems [spino-cerebellare Atrophie mit Demenz, Plaques and plaqueahnlichen im Klein- and Grosshirn (Gerstmann, Sträussler, Scheinker)]. Acta Neuropathol (Berl). 1980;49:205–212.
   PubMedGoogle Scholar
• Schlote W, Boellaard JW, Schumm F, Stohr M. Gerstmann-Sträussler-Scheinker's disease: electron microscopic observations on a brain biopsy. Acta Neuropathol (Berl). 1980;52:203–211.
   PubMedGoogle Scholar
• Schumm F, Boellaard JW, Schlote W, Stohr M. Morbus Gerstmann-Sträussler-Scheinker. Familie SCh: Ein Bericht uber drei Kranke. Arch Psychiatr Nervenkr. 1981;230:179–196.
   PubMedGoogle Scholar
• Brown P, Goldfarb LG, Brown WT, et al. Clinical and molecular genetic study of a large German kindred with Gerstmann-Sträussler-Scheinker syndrome. Neurology. 1991;41:375–379.
   PubMedGoogle Scholar
• Liberski PP, Barcikowska M, Cervenakova L, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol. 1998;96:425–430.
   PubMedGoogle Scholar
• Liberski PP, Bratosiewicz J, Barcikowska M, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol. 2000;100:233–234.
   PubMedGoogle Scholar
• Gelpi E, Kovacs GG, Ströbel T, et al. Prion disease with a 144 base pair insertion: unusual cerebellar prion protein immunoreactivity. Acta Neuropathol. 2005;110(5):513–519. [Epub 2005 Sep 10]
   PubMedGoogle Scholar
• Kopp N, Richard M, Giraud P, et al. Un cas d'insomnie fatale. Rev Neurol (Paris). 2001;157:332–333.
   Google Scholar
• Kopp N, Richard M, Liberski PP, et al. A case of fatal familial insomnia: neuropathology and biochemistry. Abstract no C34–05 in Abstracts of the XVth International Congress of Neuropathology, Birmingham, September 3–6, 2000. Brain Pathol. 2000;10:671.
   Google Scholar
• Kovacs GG, Preusser M, Strohschneider M, Budka H. Subcellular localization of disease-associated prion protein in the human brain. Am J Pathol. 2005;166:287–294.
   PubMed Web of Science ®Google Scholar
• Liberski PP, Brown P. Disease-specific particles without prion protein in prion diseases—phenomenon or epiphenomenon? Neuropathol Appl Neurobiol. 2007;33:395–397.
   PubMedGoogle Scholar
• Jellinger K. Neuroaxonal dystrophy: its natural history and related disorders, In: Zimmerman HM, ed. Progress in Neuropathology, Vol. 2. New York: Grune & Stratton; 1973:129–180.
   Google Scholar
• Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Scrapie as a model for neuroaxonal dystrophy: ultrastructural studies. Exp Neurol. 1989;106:133–141.
   PubMed Web of Science ®Google Scholar
• Kovacs GG, Kalev O, Budka H. Contribution of neuropathology to the understanding of human prion disease. Folia Neuropathol. 2004;42(Suppl A):69–76.
   PubMedGoogle Scholar
• Liberski PP, Yanagihara R, Gajdusek DC. The spongiform vacuole—the hallmark of slow virus diseases. In: Liberski PP, ed. Light and Electron Microscopic Neuropathology of Slow Virus Disorders. Boca Raton, FL: CRC Press; 1993:155–180.
   Google Scholar
• Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. The spatial patterns of prion protein deposits in cases of variant Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 2002;104:665–669.
   PubMedGoogle Scholar
• Armstrong RA, Cairns NJ, Lantos PL. Quantification of the vacuolation (spongiform change) and prion protein deposition in 11 patients with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol (Berl). 2001;102:591–596.
   PubMedGoogle Scholar
• Zlotnik I. Significance of vacuolated neurones in the medulla of sheep affected with scrapie. Nature. 1957;180:393–394.
   PubMedGoogle Scholar
• Beck E, Bak IJ, Christ JF, Gajdusek DC, Gibbs CJ Jr, Hassler R. Experimental kuru in the spider monkey: histopathological and ultrastructural studies of the brain during early stages of incubation. Brain. 1975;98:595–612.
   PubMedGoogle Scholar
• Beck E, Daniel PM, Davey AJ, Gajdusek DC, Gibbs CJ Jr. The pathogenesis of transmissible spongiform encephalopathy: an ultrastructural study. Brain. 1982;105:755–786.
   PubMedGoogle Scholar
• Liberski PP, Yanagihara R, Asher DM, Gibbs CJ Jr, Gajdusek DC. Reevaluation of the ultrastructural pathology of experimental Creutzfeldt-Jakob disease. Brain. 1990;113:121–137.
   PubMedGoogle Scholar
• Liberski PP, Yanagihara R, Wells GAH, Gibbs CJ Jr, Gajdusek DC. Ultrastructural pathology of axons and myelin in experimental scrapie in hamsters and bovine spongiform encephalopathy in cattle and a comparison with the panencephalopathic type of Creutzfeldt-Jakob disease. J Comp Pathol. 1992;106:383–398.
   PubMed Web of Science ®Google Scholar
• Jeffrey M, Scott JR, Williams A, Fraser H. Ultrastructural features of spongiform encephalopathy transmitted to mice from three species of bovidae. Acta Neuropathol (Berl). 1992;84:559–569.
   PubMedGoogle Scholar
• Kim JH, Manuelidis EE. Serial ultrastructural study of experimental Creutzfeldt-Jacob disease in guinea pigs. Acta Neuropathol. 1986;69:81–90.
   PubMedGoogle Scholar
• Liberski PP, Sikorska B, Bratosiewicz-Wasik J, Gajdusek DC, Brown P. Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: from apoptosis to autophagy. Int J Biochem Cell Biol. 2004;36:2473–2490.
   Google Scholar
• David-Ferreira JF, David-Ferreira KL, Gibbs CJ Jr, Morris JA. Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med. 1968;127:313–320.
   PubMed Web of Science ®Google Scholar
• Gibson PH, Doughty LA. An electron microscopic study of inclusion bodies in synaptic terminals of scrapie-infected animals. Acta Neuropathol (Berl). 1989;77:420–425.
   PubMedGoogle Scholar
• Liberski PP, Asher DM, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Serial ultrastructural studies of scrapie in hamsters. J Comp Pathol. 1989;101:429–442.
   PubMedGoogle Scholar
• Liberski PP, Budka H. Tubulovesicular structures in Gerstmann-Sträussler-Scheinker disease. Acta Neuropathol (Berl). 1994;88:491–492.
   PubMedGoogle Scholar
• Narang HK. An electron microscopic study of the scrapie mouse and rat: further observations on virus-like particles with ruthenium red and lanthanum nitrate as a possible trace and negative stain. Neurobiology. 1974;4:349–363.
   PubMedGoogle Scholar
• Liberski PP, Jeffrey M, Goodsir C. Tubulovesicular structures are not labeled using antibodies to prion protein (PrP) with the immunogold electron microscopy techniques. Acta Neuropathol (Berl). 1997;93:260–264.
   PubMedGoogle Scholar
• Siakotos AN, Raveed D, Longa G. The discovery of a particle unique to brain and spleen subcellular fractions from scrapie-infected mice. J Gen Virol. 1979;43:417–422.
   PubMedGoogle Scholar
• Liberski PP, Yanagihara R, Gibbs CJ Jr, Gajdusek DC. Appearance of tubulovesicular structures in experimental Creutzfeldt-Jakob disease and scrapie precedes the onset of clinical disease. Acta Neuropathol (Berl). 1990;79:349–354.
   PubMedGoogle Scholar
• Jeffrey M, Goodsir CM, Race RE, Chesebro R. Scrapie-specific neuronal lesions are independent of neuronal PrP expression. Ann Neurol. 2004;55:781–792.
   PubMed Web of Science ®Google Scholar
• Manuelidis L, Yu ZX, Barquero N, Mullins B. Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles. Proc Natl Acad Sci USA. 2007;104:1965–1970. Erratum in Proc Natl Acad Sci USA. 2007; 104:6090.
   PubMed Web of Science ®Google Scholar